CG Oncology, Inc. Common stock (CGON)
USD 29.05
(4.72%)
USD 29.05
(4.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -45.54 Million USD | 6.25% |
| 2022 | 176 Thousand USD | -98.3% |
| 2021 | 10.34 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 104 Thousand USD | -80.19% |
| 2024 Q1 | 525 Thousand USD | 17600.0% |
| 2023 Q4 | -3000.00 USD | -133.33% |
| 2023 Q2 | -4000.00 USD | 99.95% |
| 2023 FY | 187 Thousand USD | 6.25% |
| 2023 Q1 | -7.64 Million USD | -191100.0% |
| 2023 Q3 | 9000.00 USD | 325.0% |
| 2022 FY | 176 Thousand USD | -98.3% |
| 2022 Q4 | -4000.00 USD | 0.0% |
| 2021 FY | 10.34 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | -8.839% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 148.085% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 103.001% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -89667.442% |
| Apollomics, Inc. | 127 Thousand USD | 35964.567% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -43001.964% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -197934.783% |
| Bicycle Therapeutics plc | -129.52 Million USD | 64.833% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 5779.302% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 38056.667% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 327.149% |
| Chimerix, Inc. | 324 Thousand USD | 14158.025% |
| CRISPR Therapeutics AG | 240.95 Million USD | 118.903% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 191.453% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 210.057% |
| Fortress Biotech, Inc. | 57.85 Million USD | 178.731% |
| Fortress Biotech, Inc. | 57.85 Million USD | 178.731% |
| Gritstone bio, Inc. | -6.26 Million USD | -627.604% |
| Allakos Inc. | -6.14 Million USD | -641.703% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -4659.457% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 407.882% |
| Cytokinetics, Incorporated | -322.59 Million USD | 85.881% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -25927.429% |
| Innoviva, Inc. | 261.06 Million USD | 117.447% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -399163.675% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1182.681% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -453068.839% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -5070.034% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -11315.539% |
| ImmuCell Corporation | 4.39 Million USD | 1136.057% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 57.08% |
| Incyte Corporation | 3.44 Billion USD | 101.324% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -1604.942% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 23492.978% |
| Mustang Bio, Inc. | -2.22 Million USD | -1947.101% |
| MiMedx Group, Inc. | 266.84 Million USD | 117.069% |
| MEI Pharma, Inc. | 49.32 Million USD | 192.339% |
| MacroGenics, Inc. | 50.52 Million USD | 190.146% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | 713.358% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -541.01% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 256.765% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 132.487% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -146914.395% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -46856.701% |
| NextCure, Inc. | -3.68 Million USD | -1136.374% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 1869.542% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 339.185% |
| Onconetix, Inc. | -1.12 Million USD | -3940.935% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -57.236% |
| Opthea Limited | 21.72 Thousand USD | 209805.341% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -3680.293% |
| Psyence Biomedical Ltd. | -240.00 USD | -18978233.333% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -79354.349% |
| Precigen, Inc. | 106 Thousand USD | 43069.811% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 4614.172% |
| Prime Medicine, Inc. | -147.9 Million USD | 69.205% |
| PureTech Health plc | -1.6 Million USD | -2741.422% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -541.702% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.403% |
| Replimune Group, Inc. | -2.65 Million USD | -1615.556% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -181735.602% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 141.493% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -8714.389% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 88.603% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 213.87% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -0.492% |
| Solid Biosciences Inc. | -76.56 Million USD | 40.509% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -379466.667% |
| SciSparc Ltd. | 2.19 Million USD | 2174.135% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -70.63% |
| TG Therapeutics, Inc. | 219.1 Million USD | 120.788% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 1604.724% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -2534.355% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 134.045% |
| UroGen Pharma Ltd. | 73.35 Million USD | 162.095% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1140.384% |
| XOMA Corporation | 3.86 Million USD | 1279.694% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -3179.194% |
| AbCellera Biologics Inc. | 38.02 Million USD | 219.784% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -910860.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 49.065% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -46.139% |
| Precision BioSciences, Inc. | 40.47 Million USD | 212.542% |
| Dyadic International, Inc. | 922.95 Thousand USD | 5035.008% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -30885.034% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 316.267% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 10842.453% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -424.324% |
| IGM Biosciences, Inc. | -211.66 Million USD | 78.481% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -2181.964% |
| Acelyrin, Inc. | -115 Thousand USD | -39506.957% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 1970.554% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 138.035% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -240.983% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 129.425% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 53.625% |
| Senti Biosciences, Inc. | -2.68 Million USD | -1597.652% |
| Mesoblast Limited | -9.81 Million USD | -364.065% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 58.776% |
| ChromaDex Corporation | 50.78 Million USD | 189.697% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 137.807% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Seer, Inc. | 7.02 Million USD | 748.186% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 133.672% |
| Novavax, Inc. | 639.93 Million USD | 107.118% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 53.6% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -4.797% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 35136.923% |
| Celcuity Inc. | -142.77 Thousand USD | -31802.614% |
| ContextLogic Inc. | 59 Million USD | 177.2% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 8944.272% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 374.766% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.34% |
| Amarin Corporation plc | 165.54 Million USD | 127.515% |
| AnaptysBio, Inc. | 14.78 Million USD | 408.152% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -7933.157% |
| Aptorum Group Limited | -1.11 Million USD | -3986.166% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 286.283% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 118.92% |
| Ardelyx, Inc. | 106.66 Million USD | 142.704% |
| Celularity Inc. | 6.75 Million USD | 774.286% |
| Omeros Corporation | -69.77 Million USD | 34.725% |
| Humacyte, Inc. | -76.55 Million USD | 40.499% |
| Immunocore Holdings plc | 248.39 Million USD | 118.337% |
| IO Biotech, Inc. | -756 Thousand USD | -5924.868% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -3094.109% |
| Summit Therapeutics Inc. | -2.05 Million USD | -2121.854% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -849.312% |
| Pulmatrix, Inc. | -8.22 Million USD | -454.112% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 88.579% |
| Evogene Ltd. | 1.39 Million USD | 3355.754% |
| CorMedix Inc. | -205.56 Thousand USD | -22057.792% |
| BioLineRx Ltd. | 1.1 Million USD | 4210.83% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 9283.065% |
| Sagimet Biosciences Inc. | 2 Million USD | 2377.4% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 105.221% |
| scPharmaceuticals Inc. | 9.78 Million USD | 565.631% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 33.985% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 109.571% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -399163.675% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -156962.069% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -23999.471% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1224.364% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -8575.81% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -102977.759% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -336.076% |
| Daré Bioscience, Inc. | 2.76 Million USD | 1744.616% |
| bluebird bio, Inc. | -4.03 Million USD | -1030.223% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 102.392% |
| DBV Technologies S.A. | 15.72 Million USD | 389.598% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 74.892% |
| Galecto, Inc. | -830 Thousand USD | -5387.711% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -7876.883% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -15.772% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 7579.146% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -31684.844% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 183.392% |
| ADMA Biologics, Inc. | 88.21 Million USD | 151.631% |
| Clene Inc. | 533 Thousand USD | 8645.591% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 2391.147% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -9498.247% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -437861.538% |
| Soligenix, Inc. | 97.31 Thousand USD | 46906.63% |
| Century Therapeutics, Inc. | -10.8 Million USD | -321.39% |
| Kura Oncology, Inc. | -849 Thousand USD | -5264.9% |
| Surrozen, Inc. | -27.23 Million USD | -67.271% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 32.123% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 145.99% |
| Autolus Therapeutics plc | -4.86 Million USD | -835.854% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -27011.905% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 41.303% |
| GRI Bio, Inc. | 10.84 Million USD | 520.146% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 1893.238% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 2.756% |
| INmune Bio, Inc. | 155 Thousand USD | 29485.806% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 173.537% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2923.851% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6924.091% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -601590.885% |
| Jaguar Health, Inc. | 7.72 Million USD | 689.694% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -155491.993% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 11430.348% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 678.681% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -14452.077% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 148.219% |
| Verastem, Inc. | -62 Thousand USD | -73364.516% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -17351.341% |
| Histogen Inc. | 3.76 Million USD | 1308.49% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 8005.182% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 106.691% |
| Surrozen, Inc. | -27.23 Million USD | -67.271% |
| Organovo Holdings, Inc. | -5.38 Million USD | -745.203% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -2300304.04% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 850.821% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -67749.429% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 31340.055% |
| Kronos Bio, Inc. | 1.37 Million USD | 3419.825% |
| Turnstone Biologics Corp. | 16.5 Million USD | 375.948% |
| Synaptogenix, Inc. | -6347.00 USD | -717530.377% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -89209.804% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 256.367% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 128.227% |
| Exelixis, Inc. | 1.75 Billion USD | 102.591% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 59.391% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 113.473% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -4010.83% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -38340.05% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 722.41% |
| Insmed Incorporated | 239.63 Million USD | 119.007% |
| MediWound Ltd. | 3.57 Million USD | 1373.002% |
| OmniAb, Inc. | 14.66 Million USD | 410.547% |
| Alector, Inc. | -95.05 Million USD | 52.081% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 136.258% |
| Zai Lab Limited | 170.9 Million USD | 126.651% |
| AlloVir, Inc. | -398 Thousand USD | -11344.221% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 155.63% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -4313.566% |
| Aura Biosciences, Inc. | -1.29 Million USD | -3417.22% |
| Immunic, Inc. | -111 Thousand USD | -40934.234% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 387.297% |
| Veracyte, Inc. | 248.14 Million USD | 118.355% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.348% |
| FibroGen, Inc. | 128.9 Million USD | 135.335% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 114.521% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -8075786.525% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -290.404% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 11808.997% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 112.818% |
| Fortrea Holdings Inc. | 424 Million USD | 110.742% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 47.14% |
| XBiotech Inc. | -1.74 Million USD | -2511.697% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -4010.83% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -6759.639% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 1.986% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 39.699% |
| Agenus Inc. | 139.61 Million USD | 132.624% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 162.052% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 371.071% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 111.708% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 8.256% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 113.94% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -302.231% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 53.019% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 843581.481% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -68058.08% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -25950.8% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -12078.61% |
| Ainos, Inc. | -253.73 Thousand USD | -17851.153% |
| Pluri Inc. | 322 Thousand USD | 14245.342% |
| Prothena Corporation plc | -129.2 Million USD | 64.746% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 190.33% |
| Rallybio Corporation | -150 Thousand USD | -30265.333% |
| Kodiak Sciences Inc. | -25.94 Million USD | -75.542% |
| Cue Biopharma, Inc. | -32.6 Million USD | -39.688% |
| MeiraGTx Holdings plc | 287 Thousand USD | 15970.383% |
| Annexon, Inc. | -3.26 Million USD | -1294.184% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -9.131% |
| Moderna, Inc. | 2.15 Billion USD | 102.114% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -200.27% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 173.015% |
| Blueprint Medicines Corporation | 236.58 Million USD | 119.252% |
| Immix Biopharma, Inc. | -5468.00 USD | -832891.953% |
| CalciMedica, Inc. | -58 Thousand USD | -78431.034% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -632.048% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -1501.547% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 143.755% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -47.572% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -3792.991% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 1741.023% |
| Nutriband Inc. | 862.1 Thousand USD | 5383.347% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -13257.185% |
| Vor Biopharma Inc. | -3.49 Million USD | -1204.353% |
| Roivant Sciences Ltd. | 109.23 Million USD | 141.697% |
| Alkermes plc | 1.37 Billion USD | 103.313% |
| ProKidney Corp. | -3.16 Million USD | -1337.299% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -3.726% |
| Arcellx, Inc. | 108.27 Million USD | 142.065% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 764.256% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 42.103% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -137924.242% |
| Atai Life Sciences N.V. | -5000.00 USD | -910860.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -37277.625% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -47345.833% |
| MediciNova, Inc. | 979.7 Thousand USD | 4749.155% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 45.981% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -48070.906% |
| GeoVax Labs, Inc. | -20.72 Million USD | -119.818% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 118.626% |
| Biomea Fusion, Inc. | -4.2 Million USD | -984.218% |
| RenovoRx, Inc. | - USD | Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -14592.903% |
| Geron Corporation | -123.5 Million USD | 63.12% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -910860.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 40.361% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -1750.792% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 121.311% |
| Royalty Pharma plc | 1.79 Billion USD | 102.539% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -4740.383% |
| Imunon, Inc. | -720 Thousand USD | -6226.067% |
| BioAtla, Inc. | -103.73 Million USD | 56.09% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 81.242% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -14545.659% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 59.118% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -4698.699% |
| 89bio, Inc. | -273 Thousand USD | -16584.249% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 35.01% |
| aTyr Pharma, Inc. | -2.38 Million USD | -1807.37% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 465.554% |
| Viridian Therapeutics, Inc. | -1 Million USD | -4418.651% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 350369330.769% |
| Akari Therapeutics, Plc | -4000.00 USD | -1138600.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 107.152% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 4170.42% |
| Liquidia Corporation | 14.6 Million USD | 411.973% |
| Entera Bio Ltd. | -56 Thousand USD | -81235.714% |
| GH Research PLC | -315 Thousand USD | -14359.683% |
| Vericel Corporation | 135.57 Million USD | 133.596% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 18.019% |
| Xencor, Inc. | -85.26 Million USD | 46.578% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -20512.1% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6924.091% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -4449.177% |
| Vaxcyte, Inc. | -75 Million USD | 39.269% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 72.809% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 125.611% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 23492.978% |
| Portage Biotech Inc. | -54 Thousand USD | -84248.148% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -48070.906% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -11981.698% |
| OncoCyte Corporation | 413 Thousand USD | 11128.571% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1013203.671% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -20517017.117% |
| Purple Biotech Ltd. | -196 Thousand USD | -23138.776% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -11854.856% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -107.159% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 166.858% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 607.895% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -35764.567% |
| United Therapeutics Corporation | 2.07 Billion USD | 102.2% |
| HilleVax, Inc. | -2.15 Million USD | -2012.616% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 68837.173% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -1055.44% |
| Pharming Group N.V. | 220.1 Million USD | 120.694% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -303472.381% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -6718.563% |
| Pyxis Oncology, Inc. | -2 Million USD | -2177.4% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -606708.275% |
| Savara Inc. | -44.26 Million USD | -2.905% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -55446.341% |
| Curis, Inc. | 9.81 Million USD | 564.254% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -36400.305% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -19877.193% |
| BeiGene, Ltd. | 2.07 Billion USD | 102.191% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 180.349% |
| Erasca, Inc. | -3.73 Million USD | -1120.472% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -161314.7% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -161314.7% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -4877.923% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 668.923% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -8397.761% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 59.013% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1169.454% |
| Adicet Bio, Inc. | -6.09 Million USD | -646.933% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 112.581% |
| Aditxt, Inc. | -111.66 Thousand USD | -40691.689% |
| Adagene Inc. | 18.11 Million USD | 351.487% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 9433.607% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 128.858% |
| Compugen Ltd. | 31.45 Million USD | 244.804% |
| Generation Bio Co. | -73.91 Million USD | 38.375% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -10322.883% |
| Invivyd, Inc. | -2.02 Million USD | -2145.957% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 84.86% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -43934.107% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 147.265% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 146.341% |
| Instil Bio, Inc. | -4.75 Million USD | -857.696% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 288.924% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 4114.525% |
| GeoVax Labs, Inc. | -20.72 Million USD | -119.818% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -23340.17% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -5348.325% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 154.604% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 62398.939% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 185.678% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 73.7% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -12803.116% |
| Cingulate Inc. | -582.91 Thousand USD | -7713.792% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -146829.032% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -131.22% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -4510.121% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -80742.001% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 15.127% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -15498.63% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -8542.884% |
| ImmunityBio, Inc. | -17.89 Million USD | -154.6% |
| Korro Bio, Inc. | -3.63 Million USD | -1154.766% |
| Kineta, Inc. | 5.43 Million USD | 938.358% |
| BioVie Inc. | -229.37 Thousand USD | -19757.266% |
| Codexis, Inc. | 57.33 Million USD | 179.443% |
| Celularity Inc. | 6.75 Million USD | 774.286% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -38175.63% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1235.011% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 90133.603% |
| Cibus, Inc. | 1.42 Million USD | 3303.094% |
| IN8bio, Inc. | -2.5 Million USD | -1721.192% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -2128.376% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 7216.875% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 105.851% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 126.335% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | -116689.744% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -2297.263% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -40.715% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 157.507% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -115.337% |
| Moolec Science SA | -143.3 Thousand USD | -31683.957% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -7.633% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 1485.701% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 35.015% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -2309.947% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1260918.826% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 19784.43% |
| Humacyte, Inc. | -76.55 Million USD | 40.499% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -3523.548% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -5271.226% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -36930.894% |
| Notable Labs, Ltd. | 113 Thousand USD | 40407.965% |
| Immunovant, Inc. | -231 Thousand USD | -19617.749% |
| Quantum-Si incorporated | 488 Thousand USD | 9433.607% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -151726.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 2546.187% |
| Acasti Pharma Inc. | -11 Thousand USD | -413972.727% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -22160.125% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -2226.251% |
| PepGen Inc. | -1.18 Million USD | -3746.959% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -98.926% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -55054.208% |
| Immuneering Corporation | -764.13 Thousand USD | -5860.703% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Belite Bio, Inc | -399 Thousand USD | -11315.539% |
| XOMA Corporation | 3.86 Million USD | 1279.694% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -127.331% |
| Bionomics Limited | -434.44 Thousand USD | -10384.084% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -4140.968% |
| uniQure N.V. | 2.21 Million USD | 2156.343% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 50.528% |
| Forte Biosciences, Inc. | -9000.00 USD | -505988.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -5354.85% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -10322.883% |
| Altimmune, Inc. | -65.37 Million USD | 30.326% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -1792.314% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -4140.968% |
| Peak Bio, Inc. | 367.76 Thousand USD | 12484.948% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 285.789% |
| Benitec Biopharma Inc. | 108 Thousand USD | 42274.074% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -58294.872% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -3686.201% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -2399.89% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -3686.201% |
| argenx SE | 1.1 Billion USD | 104.109% |
| Immunome, Inc. | -8.9 Million USD | -411.373% |
| Verona Pharma plc | -679.62 Thousand USD | -6601.941% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -25927.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | -1809.769% |
| CervoMed Inc. | -1.29 Million USD | -3420.953% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -853.485% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 1943.302% |
| Moolec Science SA | -143.3 Thousand USD | -31683.957% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -11062.905% |
| Design Therapeutics, Inc. | -537 Thousand USD | -8381.937% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -10566.979% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 2222.46% |
| Achilles Therapeutics plc | -4.73 Million USD | -862.702% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 106025.581% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -5441.119% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -346062.031% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -137924.242% |
| Beam Therapeutics Inc. | -59.67 Million USD | 23.669% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 132.69% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 311.409% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -15236.027% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1031.055% |
| NeurAxis, Inc. | 2.15 Million USD | 2211.926% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -376.145% |
| Lumos Pharma, Inc. | 2 Million USD | 2369.457% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 243.872% |
| Palisade Bio, Inc. | 246 Thousand USD | 18615.447% |
| Nutriband Inc. | 862.1 Thousand USD | 5383.347% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 423.494% |
| Neurogene Inc. | -3.26 Million USD | -1296.321% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -82714.545% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1133.694% |
| Athira Pharma, Inc. | -969 Thousand USD | -4600.516% |
| HCW Biologics Inc. | -574.82 Thousand USD | -7823.817% |
| XOMA Corporation | 3.86 Million USD | 1279.694% |
| Nektar Therapeutics | 53.47 Million USD | 185.171% |
| Arvinas, Inc. | 71.8 Million USD | 163.437% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 45.426% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 27.442% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -14045.342% |
| Rezolute, Inc. | -36 Thousand USD | -126422.222% |
| Clene Inc. | 533 Thousand USD | 8645.591% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -3547252.025% |
| BeyondSpring Inc. | 1.75 Million USD | 2701.256% |
| Synlogic, Inc. | -1.92 Million USD | -2267.36% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -123002.703% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -619.33% |
| Peak Bio, Inc. | 367.76 Thousand USD | 12484.948% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -140.194% |
| Krystal Biotech, Inc. | 47.6 Million USD | 195.679% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 132.283% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1006.428% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -1659.14% |
| MannKind Corporation | 136.19 Million USD | 133.444% |
| Ikena Oncology, Inc. | -50.49 Million USD | 9.792% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 141.859% |
| Gossamer Bio, Inc. | -4.38 Million USD | -938.723% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -17974.603% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -910860.0% |
| Legend Biotech Corporation | 140.92 Million USD | 132.32% |
| Mural Oncology plc | -2.56 Million USD | -1674.367% |
| Disc Medicine, Inc. | -100 Thousand USD | -45448.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 319.466% |
| REGENXBIO Inc. | 53.02 Million USD | 185.893% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -750.259% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -23576.673% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -2529.792% |
| Vaxart, Inc. | -60.76 Million USD | 25.04% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -17233.13% |
| Cellectis S.A. | 18 Thousand USD | 253144.444% |
| Longeveron Inc. | 221 Thousand USD | 20709.955% |
| Repare Therapeutics Inc. | -80.07 Million USD | 43.115% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 104.167% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -3419.938% |
| Revolution Medicines, Inc. | -399.66 Million USD | 88.603% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -130037.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 93055.102% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.529% |
| Denali Therapeutics Inc. | -93.34 Million USD | 51.205% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -181735.602% |
| Veru Inc. | 7.56 Million USD | 702.015% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -30064.238% |
| Cingulate Inc. | -582.91 Thousand USD | -7713.792% |
| Passage Bio, Inc. | -3.72 Million USD | -1124.08% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -378080.007% |
| Exicure, Inc. | -1.42 Million USD | -3100.843% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -11792.428% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 1785.091% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -8784.381% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -30345.099% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 23.069% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 11749.105% |
| OmniAb, Inc. | 14.66 Million USD | 410.547% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 327.82% |
| Lipocine Inc. | -2.85 Million USD | -1497.717% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -2371.405% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -698.387% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2923.851% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 160.476% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -69973.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 154.033% |
| Ocugen, Inc. | -33.53 Million USD | -35.814% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1340.481% |
| Q32 Bio Inc. | 578 Thousand USD | 7980.277% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -17087.925% |
| Alumis Inc. Common Stock | -1.28 Million USD | -3447.352% |
| Equillium, Inc. | 35.95 Million USD | 226.67% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -2568.307% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 9197.246% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1101690.034% |
| Dominari Holdings Inc. | 2.03 Million USD | 2333.84% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -24725.722% |
| vTv Therapeutics Inc. | -13.59 Million USD | -235.035% |
| Bio-Techne Corporation | 773.07 Million USD | 105.892% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 362.994% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 109.885% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -3796.322% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -89.942% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 489.399% |
| Nkarta, Inc. | -5.86 Million USD | -676.078% |
| BioCardia, Inc. | -7.24 Million USD | -528.335% |
| Iterum Therapeutics plc | -1.75 Million USD | -2502.743% |